Mr. Wu received a bachelor’s degree in economics and a master’s degree in business administration from Shanghai Jiaotong University. He has extensive connections and more than 20 years of rich experience in the fields of domestic and foreign capital market operations, pharmaceutical industry strategic development, mergers and acquisitions, business development and financial management. Before joining Sinopharm Group, Mr. Wu served as the chief financial officer of VV (600300) and participated in the A-share listing of VV. After joining Sinopharm Group in 2003, Mr. Wu successively served as chief financial officer, deputy general manager and secretary of the board of Sinopharm Holdings (HK 1099), and served as director of Accord Pharmaceutical (000028) and Sinopharm (600511). He has played an important role in the reorganization, mergers and acquisitions, listing operations and business operations of the Sinopharm Group system: responsible for the listing of H-shares of Sinopharm; the share reform and reorganization of Accord Pharmaceutical and Sinopharm; as the investment leader of Sinopharm, responsible for nearly 20 The remaining cases of investment decision-making, execution, and post-investment business restructuring of investment and acquisition projects.